Cargando…

Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors

Eukaryotes use autophagy as a mechanism for maintaining cellular homeostasis by degrading and recycling organelles and proteins. This process assists in the proliferation and survival of advanced cancers. There is mounting preclinical evidence that targeting autophagy can enhance the efficacy of man...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chude, Cynthia I., Amaravadi, Ravi K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5486101/ https://www.ncbi.nlm.nih.gov/pubmed/28621712 http://dx.doi.org/10.3390/ijms18061279

Ejemplares similares

Clinical Translation of Combined MAPK and Autophagy Inhibition in RAS Mutant Cancer
por: Lee, Jennifer J., et al.
Publicado: (2021)

Recent insights into the function of autophagy in cancer
por: Amaravadi, Ravi, et al.
Publicado: (2016)

Autophagy and tumor cell invasion
por: Amaravadi, Ravi K.
Publicado: (2012)

Advanced targeted nanomedicine: a communication engineering solution
por: Chude-Okonkwo, Uche, et al.
Publicado: (2019)

Update on Autophagy Inhibitors in Cancer: Opening up to a Therapeutic Combination with Immune Checkpoint Inhibitors
por: Bestion, Eloïne, et al.
Publicado: (2023)

Dimeric quinacrines as chemical tools to identify PPT1, a new regulator of autophagy in cancer cells
por: Nicastri, Michael C., et al.
Publicado: (2017)

Targeting the Interplay of Autophagy and ROS for Cancer Therapy: An Updated Overview on Phytochemicals
por: Dong, Lixia, et al.
Publicado: (2023)

A Potent Autophagy Inhibitor (Lys05) Enhances the Impact of Ionizing Radiation on Human Lung Cancer Cells H1299
por: Cechakova, Lucie, et al.
Publicado: (2019)

Enhancing Anti-Cancer Therapy with Selective Autophagy Inhibitors by Targeting Protective Autophagy
por: Lee, Min Ju, et al.
Publicado: (2023)

Targeting quiescent leukemic stem cells using second generation autophagy inhibitors
por: Baquero, Pablo, et al.
Publicado: (2018)

Novel Inhibitor-Based Therapies for Thyroid Cancer—An Update
por: Ratajczak, Maciej, et al.
Publicado: (2021)

The Renaissance of CDK Inhibitors in Breast Cancer Therapy: An Update on Clinical Trials and Therapy Resistance
por: Abdelmalak, Mary, et al.
Publicado: (2022)

Small Molecule Inhibitors for Unc-51-like Autophagy-Activating Kinase Targeting Autophagy in Cancer
por: Karmacharya, Ujjwala, et al.
Publicado: (2023)

CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers
por: Vijayaraghavan, Smruthi, et al.
Publicado: (2017)

The Emerging Role of Autophagy as a Target of Environmental Pollutants: An Update on Mechanisms
por: Rahman, Md. Ataur, et al.
Publicado: (2023)

Molecular Targets in Precision Chemoprevention of Colorectal Cancer: An Update from Pre-Clinical to Clinical Trials
por: Yarla, Nagendra S., et al.
Publicado: (2020)

Irisin and Autophagy: First Update
por: Pesce, Mirko, et al.
Publicado: (2020)

The Role and Mechanism of Autophagy in Pancreatic Cancer: An Update Review
por: Ma, Jian, et al.
Publicado: (2021)

Renal toxicity with mammalian target of rapamycin inhibitors: A meta-analysis of randomized clinical trials
por: Paluri, Ravi K., et al.
Publicado: (2019)

Recent Update and Drug Target in Molecular and Pharmacological Insights into Autophagy Modulation in Cancer Treatment and Future Progress
por: Rahman, Md. Ataur, et al.
Publicado: (2023)

PUMA: a puzzle piece in chloroquine’s antimelanoma activity
por: Amaravadi, Ravi K.
Publicado: (2013)

Chasing the Target: New Phenomena of Resistance to Novel Selective RET Inhibitors in Lung Cancer. Updated Evidence and Future Perspectives
por: Fancelli, Sara, et al.
Publicado: (2021)

Novel targeted therapies in chordoma: an update
por: Di Maio, Salvatore, et al.
Publicado: (2015)

Targeting TIGIT for Immunotherapy of Cancer: Update on Clinical Development
por: Rotte, Anand, et al.
Publicado: (2021)

Novel histone deacetylase inhibitors in clinical trials as anti-cancer agents
por: Tan, Jiahuai, et al.
Publicado: (2010)

Is autophagy induction by PARP inhibitors a target for therapeutic benefit?
por: ELSHAZLY, AHMED M., et al.
Publicado: (2022)

Epigenetic therapy in urologic cancers: an update on clinical trials
por: Faleiro, Inês, et al.
Publicado: (2016)

An update on PARP inhibitors for the treatment of cancer
por: Benafif, Sarah, et al.
Publicado: (2015)

Targeting Autophagy in Breast Cancer
por: Cocco, Stefania, et al.
Publicado: (2020)

Triple-Negative Breast Cancer: An Update on Neoadjuvant Clinical Trials
por: Amos, Keith D., et al.
Publicado: (2012)

An Update on Nucleolar Stress: The Transcriptional Control of Autophagy
por: Pfister, Astrid S.
Publicado: (2023)

KSHV Targeted Therapy: An Update on Inhibitors of Viral Lytic Replication
por: Coen, Natacha, et al.
Publicado: (2014)

Discovery of the novel autophagy inhibitor aumitin that targets mitochondrial complex I
por: Robke, Lucas, et al.
Publicado: (2018)

Clinical Applications of Autophagy Proteins in Cancer: From Potential Targets to Biomarkers
por: Bortnik, Svetlana, et al.
Publicado: (2017)

Targeting autophagy in prostate cancer: preclinical and clinical evidence for therapeutic response
por: Ashrafizadeh, Milad, et al.
Publicado: (2022)

Autophagy: A Novel Therapeutic Target for Diabetic Nephropathy
por: Kume, Shinji, et al.
Publicado: (2015)

The Mediterranean Diet: An Update of the Clinical Trials
por: Finicelli, Mauro, et al.
Publicado: (2022)

Autophagy Agents in Clinical Trials for Cancer Therapy: A Brief Review
por: Mohsen, Samiha, et al.
Publicado: (2022)

Targeting Autophagy in ALK-Associated Cancers
por: Frentzel, Julie, et al.
Publicado: (2017)

Application of Janus Kinase Inhibitors in Atopic Dermatitis: An Updated Systematic Review and Meta-Analysis of Clinical Trials
por: Tsai, Hou-Ren, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_901bn2v3ehssjn3uc59j0qqbpv